OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in diagnostic tests and specimen collection devices, announced Dr. Stephen S. Tang's participation in the Raymond James 2021 Human Health Innovation Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in diagnostic tests and specimen collection devices, announced Dr. Stephen S. Tang's participation in the Raymond James 2021 Human Health Innovation Conference. Scheduled for June 23, 2021, at 11:20 AM EDT, the event will be webcast live, accessible via OraSure Technologies' website. A replay will also be available for 14 days. OraSure is committed to enhancing health and wellness with its innovative diagnostic solutions offered globally across various healthcare sectors.
Details
News Market Reaction – OSUR
The recorded move for OSUR in the trading session of this news was -1.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BETHLEHEM, Pa., June 17, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Raymond James 2021 Human Health Innovation Conference. The conference will be simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on June 23, 2021, at 11:20 AM EDT. The live webcast of the presentation can be accessed by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for 14 days. Alternatively, you can access the live webcast of the presentation here.
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.
Company contacts:
Investor Contact:
Scott Gleason
SVP Investor Relations & Corporate Communications
484-425-0588
sgleason@orasure.com
Media Contact:
Amy Koch
Sr. Mgr. Corporate Communications
484-523-1815
media@orasure.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.